Business Description
Kwang Dong Pharmaceutical Co Ltd
ISIN : KR7009290008
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.75 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | 3.92 | |||||
Interest Coverage | 2.85 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.61 | |||||
Beneish M-Score | -2.13 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.8 | |||||
3-Year EBITDA Growth Rate | -6.8 | |||||
3-Year EPS without NRI Growth Rate | -5 | |||||
3-Year Book Growth Rate | 5.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.29 | |||||
9-Day RSI | 53.35 | |||||
14-Day RSI | 52.81 | |||||
6-1 Month Momentum % | -14.02 | |||||
12-1 Month Momentum % | -24.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.41 | |||||
Quick Ratio | 0.98 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 54.63 | |||||
Days Sales Outstanding | 59.34 | |||||
Days Payable | 48.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.78 | |||||
Dividend Payout Ratio | 0.29 | |||||
Forward Dividend Yield % | 1.78 | |||||
5-Year Yield-on-Cost % | 2.29 | |||||
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | -38.11 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 18.28 | |||||
Operating Margin % | 1.63 | |||||
Net Margin % | 2.07 | |||||
FCF Margin % | -4.78 | |||||
ROE % | 6.09 | |||||
ROA % | 3.07 | |||||
ROIC % | 2.69 | |||||
ROC (Joel Greenblatt) % | 13.58 | |||||
ROCE % | 9.6 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 6.65 | |||||
PE Ratio without NRI | 16.15 | |||||
PEG Ratio | 10.09 | |||||
PS Ratio | 0.14 | |||||
PB Ratio | 0.4 | |||||
Price-to-Tangible-Book | 0.42 | |||||
EV-to-EBIT | 5.63 | |||||
EV-to-EBITDA | 4.6 | |||||
EV-to-Revenue | 0.2 | |||||
EV-to-FCF | -3.86 | |||||
Price-to-Projected-FCF | 0.47 | |||||
Price-to-Median-PS-Value | 0.53 | |||||
Price-to-Graham-Number | 0.55 | |||||
Price-to-Net-Current-Asset-Value | 2.06 | |||||
Earnings Yield (Greenblatt) % | 17.78 | |||||
FCF Yield % | -34.6 | |||||
Forward Rate of Return (Yacktman) % | 2.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kwang Dong Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 1,634,197.694 | ||
EPS (TTM) (â‚©) | 846 | ||
Beta | 0.38 | ||
Volatility % | 15.9 | ||
14-Day RSI | 52.81 | ||
14-Day ATR (â‚©) | 140.426499 | ||
20-Day SMA (â‚©) | 5563 | ||
12-1 Month Momentum % | -24.9 | ||
52-Week Range (â‚©) | 5010 - 8500 | ||
Shares Outstanding (Mil) | 40.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kwang Dong Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kwang Dong Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kwang Dong Pharmaceutical Co Ltd Frequently Asked Questions
What is Kwang Dong Pharmaceutical Co Ltd(XKRX:009290)'s stock price today?
When is next earnings date of Kwang Dong Pharmaceutical Co Ltd(XKRX:009290)?
Does Kwang Dong Pharmaceutical Co Ltd(XKRX:009290) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |